<DOC>
	<DOCNO>NCT00445328</DOCNO>
	<brief_summary>The purpose study compare efficacy safety dalteparin v unfractionated heparin prevention VTE ( Venous Thromboembolism ) hospitalize acutely ill medical patient .</brief_summary>
	<brief_title>Dalteparin v Unfractionated Heparin For The Prevention Of Venous Thromboembolism ( VTE ) In Hospitalized Acutely Ill Medical Patients</brief_title>
	<detailed_description>The study prematurely discontinue due delay overall study start-up inability meet pre-defined protocol recruitment milestone June 30th , 2008 . There safety concern regard study decision terminate trial .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>Aged great equal 18 year Acute medical condition project hospitalization great equal 4 day less equal 3 day prior immobilization two third day Acute congestive heart failure Class IIIIV per NHYA/ Acute respiratory failure require mechanical ventilation Both Acute infection without septic shock/ Acute episode inflammatory bowel disease/ Acute rheumatologic disorders/ Acute lumbar pain sciatica vertebral compression least one risk factor VTE Contraindications use anticoagulant Active bleed abnormal coagulation test Recent ( less 1 month ) head injury , hemorrhagic stroke , cerebral tumor intracranial aneurysm ischemic stroke within last month . Major surgical invasive procedure within last month result ongoing convalescence Lumbar spinal puncture within last 48 hour S creatinine level 2 On inotropic agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>hospitalise acutely medically ill patient ; Venous Thromboembolism , Infection , Inflammatory Bowel Diseases , Heart Failure , Congestive , Sciatica</keyword>
</DOC>